JO3282B1 - Liposome Composition - Google Patents

Liposome Composition

Info

Publication number
JO3282B1
JO3282B1 JOP/2010/0318A JOP20100318A JO3282B1 JO 3282 B1 JO3282 B1 JO 3282B1 JO P20100318 A JOP20100318 A JO P20100318A JO 3282 B1 JO3282 B1 JO 3282B1
Authority
JO
Jordan
Prior art keywords
liposome composition
manufacture
provides
composition containing
present
Prior art date
Application number
JOP/2010/0318A
Other languages
Arabic (ar)
Inventor
Hyodo Kenji
Ishihara Hiroshi
Kikuchi Hiroshi
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Priority to JOP/2010/0318A priority Critical patent/JO3282B1/en
Application granted granted Critical
Publication of JO3282B1 publication Critical patent/JO3282B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention provides a novel liposome composition containing eribulin or its pharmacologically permissible salt, and its method of manufacture
JOP/2010/0318A 2010-09-16 2010-09-16 Liposome Composition JO3282B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JOP/2010/0318A JO3282B1 (en) 2010-09-16 2010-09-16 Liposome Composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JOP/2010/0318A JO3282B1 (en) 2010-09-16 2010-09-16 Liposome Composition

Publications (1)

Publication Number Publication Date
JO3282B1 true JO3282B1 (en) 2018-09-16

Family

ID=63684646

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2010/0318A JO3282B1 (en) 2010-09-16 2010-09-16 Liposome Composition

Country Status (1)

Country Link
JO (1) JO3282B1 (en)

Similar Documents

Publication Publication Date Title
JOP20180103B1 (en) PHARMACEUTICAL COMPOSITION of CARBETOCIN
MY181898A (en) Heterocyclic compounds and uses thereof
TW201231056A (en) Metal salt compositions
UA103794C2 (en) Liposome composition
SG10201908576VA (en) Use of remote ischemic conditioning for traumatic injury
IN2012DN03883A (en)
TN2011000673A1 (en) Bace inhibitors
PT2431442T (en) Composition of 1,3,3,3-tetrafluoropropene
MX2011009369A (en) Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators.
IN2014DN10670A (en)
MX348325B (en) Galacto-oligosaccharide-containing composition and a method of producing it.
MX2011014019A (en) Diazahomoadamantane derivatives and methods of use thereof.
MX2013004981A (en) Compositions and methods for the delivery of therapeutics.
HK1221213A1 (en) Novel calcium salts of compound as anti-inflammatory, immunomodulatory and anti-proliferatory agents
MX2013002784A (en) Fused heteroaryls and their uses.
MX370253B (en) Compositions of jasmonate compounds and methods of use.
WO2013055687A3 (en) R(+)-n-formyl-propargyl-aminoindan
MX2011008825A (en) Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators.
PH12014502876A1 (en) Pharmaceutical composition containing fimasartan and hydrochlorothiazide
MX2011008662A (en) Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators.
MX2011009338A (en) Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators.
UA103996C2 (en) Ivabradine hydrobromide
IN2012DN03379A (en)
MX2012010443A (en) Process for the preparation of 5-substituted 1-alkyltetrazoles.
MX2012010317A (en) β-hydroxyalkylamides, method for their production and use thereof.